RA Capital Nexus Fund III, L.P. — SEC insider filings
SEC reporting owner CIK 1883840. 57 insider filings on record with FilingPulse; latest filed 2026-11-18.
Transaction summary — filings shown
Covers the 50 most recent of 57 filings on record, filed 2024-09-18 to 2026-11-18. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 49 legs across 24 filings — 47,312,144 shares, $819,231,795 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 48 legs across 5 filings — 5,482,088 shares, $106,750,983 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 82.
- Largest priced transaction: purchase of 19,728,353 shares @ $20.00 ($394,567,060) in Parabilis Medicines, Inc., filed 2026-06-15.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Parabilis Medicines, Inc. (PBLS) | Director | 3 | 8 legs · 21,433,343 sh · $430,694,551 | — | 7 |
| Septerna, Inc. (SEPN) | Director | 4 | 2 legs · 4,170,000 sh · $75,060,000 | 2 legs · 1,493,000 sh · $63,452,500 | 6 |
| Artiva Biotherapeutics, Inc. (ARTV) | Director | 13 | 20 legs · 8,642,543 sh · $92,678,453 | — | 4 |
| Sionna Therapeutics, Inc. (SION) | Director | 7 | 2 legs · 1,125,000 sh · $20,250,000 | 46 legs · 3,989,088 sh · $43,298,483 | 16 |
| SpyGlass Pharma, Inc. (SGP) | Director | 3 | 3 legs · 3,691,000 sh · $59,072,430 | — | 9 |
| Mineralys Therapeutics, Inc. (MLYS) | Director | 5 | 4 legs · 2,841,766 sh · $56,262,778 | — | 3 |
| Bambusa Therapeutics, Inc. (BBTX) | Director | 2 | 4 legs · 2,953,820 sh · $46,639,957 | — | 6 |
| Bicara Therapeutics Inc. (BCAX) | Director | 4 | 3 legs · 2,133,000 sh · $37,794,000 | — | 9 |
| Climb Bio, Inc. (CLYM) | Director | 7 | 3 legs · 321,672 sh · $779,626 | — | 14 |
| Freenome, Inc. (FRNM) | Director | 1 | — | — | 7 |
+1 more issuer among the filings shown — every filing appears in the table below.
Insider filings — RA Capital Nexus Fund III, L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-18 | 4 | SpyGlass Pharma, Inc. (SGP) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 1,000 @ $32.43 | EDGAR |
| 2026-11-03 | 4 | Bambusa Therapeutics, Inc. (BBTX) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 189,909 @ $14.23 · Purchase (P): 263,911 @ $14.92 · Conversion (C): 3,144,858 · Conversion (C): 1,331,080 · Purchase (P): 2,335,109 @ $16 · Purchase (P): 164,891 @ $16 · +4 more | EDGAR |
| 2026-10-29 | 3 | Bambusa Therapeutics, Inc. (BBTX) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Holdings only — no transactions reported | EDGAR |
| 2026-09-30 | 4 | Climb Bio, Inc. (CLYM) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M. | Option exercise (M): 10,000 @ $3.46 · Option exercise (M): 10,000 @ $3 · Option exercise (M): 10,000 @ $7.89 · Option exercise (M): 40,000 @ $1.29 · Option exercise (M): 10,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 · +2 more | EDGAR |
| 2026-09-21 | 4 | Sionna Therapeutics, Inc. (SION) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Sale (S): 3,415,011 @ $6.32 · Sale (S): 33,800 @ $7.46 | EDGAR |
| 2026-09-14 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 16,250 (derivative) @ $0 | EDGAR |
| 2026-09-08 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2026-08-14 | 4 | Septerna, Inc. (SEPN) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Sale (S): 746,500 @ $42.50 · Sale (S): 746,500 @ $42.50 | EDGAR |
| 2026-07-31 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 20,824 @ $9.99 · Purchase (P): 24,944 @ $9.93 | EDGAR |
| 2026-07-28 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 41,319 @ $9.99 | EDGAR |
| 2026-07-23 | 4/A | Artiva Biotherapeutics, Inc. (ARTV) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 6,522 @ $8.94 | EDGAR |
| 2026-07-23 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 120,582 @ $9.55 · Purchase (P): 84,124 @ $9.93 · Purchase (P): 59,880 @ $9.96 | EDGAR |
| 2026-07-22 | 4 | Parabilis Medicines, Inc. (PBLS) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 98,433 @ $27.13 · Purchase (P): 32,987 @ $27.72 · Purchase (P): 21,696 @ $27.96 · Purchase (P): 6,504 @ $29.17 · Purchase (P): 37,723 @ $30 · Purchase (P): 47,250 @ $29.77 | EDGAR |
| 2026-07-22 | 4 | Freenome, Inc. (FRNM) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 6,561,711 · Grant/award (A): 970,950 · Grant/award (A): 553,703 · Grant/award (A): 908,103 · Grant/award (A): 367,427 · Grant/award (A): 4,918,411 @ $10 · +1 more | EDGAR |
| 2026-07-20 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 152,472 @ $8.93 · Purchase (P): 7,882 @ $8.95 | EDGAR |
| 2026-07-14 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 15,102 @ $8.97 · Purchase (P): 6,552 @ $8.94 | EDGAR |
| 2026-07-01 | 4 | Climb Bio, Inc. (CLYM) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 70,284 (derivative) @ $0 | EDGAR |
| 2026-06-30 | 4 | Septerna, Inc. (SEPN) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-06-29 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 31,000 @ $8.88 · Purchase (P): 1,876 @ $8.98 | EDGAR |
| 2026-06-18 | 4 | Sionna Therapeutics, Inc. (SION) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 17,340 (derivative) @ $0 | EDGAR |
| 2026-06-16 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 391,019 @ $8.57 · Purchase (P): 15,414 @ $8.99 · Purchase (P): 124,893 @ $8.89 | EDGAR |
| 2026-06-15 | 4 | Parabilis Medicines, Inc. (PBLS) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Conversion (C): 6,556,740 · Conversion (C): 1,187,881 · Purchase (P): 19,728,353 @ $20 · Purchase (P): 1,460,397 @ $20 · Conversion (C): 642,250 (derivative) · Conversion (C): 160,562 (derivative) · +2 more | EDGAR |
| 2026-06-11 | 4 | Parabilis Medicines, Inc. (PBLS) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 20,215 (derivative) @ $0 | EDGAR |
| 2026-06-11 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 479,039 @ $6.91 · Purchase (P): 103 @ $7 · Purchase (P): 548,580 @ $7.91 | EDGAR |
| 2026-06-10 | 4 | Bicara Therapeutics Inc. (BCAX) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 19,475 (derivative) @ $0 | EDGAR |
| 2026-06-08 | 4 | Climb Bio, Inc. (CLYM) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2026-05-13 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 6,510,416 @ $11.52 · Purchase (P): 2,170,138 (derivative) @ $11.52 | EDGAR |
| 2026-04-29 | 4 | Climb Bio, Inc. (CLYM) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 2,106,000 (derivative) @ $9.50 | EDGAR |
| 2026-03-31 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 310,700 @ $23.67 · Purchase (P): 58,300 @ $24.16 | EDGAR |
| 2026-03-02 | 4 | Bicara Therapeutics Inc. (BCAX) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 300,000 @ $16 · Purchase (P): 2,200,000 (derivative) @ $16.00 | EDGAR |
| 2026-02-20 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 6,200 @ $0 · Grant/award (A): 8,300 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Evommune, Inc. (EVMN) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 35,868 @ $27.88 | EDGAR |
| 2026-02-11 | 4 | SpyGlass Pharma, Inc. (SGP) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Conversion (C): 2,524,473 · Conversion (C): 1,806,644 · Purchase (P): 3,441,966 @ $16 · Purchase (P): 248,034 @ $16 · Conversion (C): 1,150,941 (derivative) · Conversion (C): 767,294 (derivative) · +4 more | EDGAR |
| 2026-02-09 | 4 | SpyGlass Pharma, Inc. (SGP) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 27,400 (derivative) @ $0 | EDGAR |
| 2026-01-07 | 4 | Climb Bio, Inc. (CLYM) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 7,111 @ $3.50 | EDGAR |
| 2025-12-15 | 4 | Climb Bio, Inc. (CLYM) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M. | Disposition to issuer (D): 20,440,000 @ $0 · Purchase (P): 213,099 @ $2.18 · Purchase (P): 101,462 @ $2.86 · Grant/award (A): 20,440,000 (derivative) | EDGAR |
| 2025-11-24 | 4 | Sionna Therapeutics, Inc. (SION) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Sale (S): 150 @ $39.89 · Sale (S): 1,235 @ $39.89 · Sale (S): 801 @ $39.89 · Sale (S): 947 @ $39.89 · Sale (S): 96 @ $40.50 · Sale (S): 788 @ $40.50 · +6 more | EDGAR |
| 2025-11-19 | 4 | Sionna Therapeutics, Inc. (SION) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Sale (S): 2,182 @ $40.20 · Sale (S): 17,913 @ $40.20 · Sale (S): 11,626 @ $40.20 · Sale (S): 13,734 @ $40.20 · Sale (S): 1,701 @ $41.05 · Sale (S): 13,964 @ $41.05 · +18 more | EDGAR |
| 2025-10-28 | 4 | Sionna Therapeutics, Inc. (SION) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Sale (S): 14,116 @ $39.50 · Sale (S): 122,271 @ $39.50 · Sale (S): 66,672 @ $39.50 · Sale (S): 107,941 @ $39.50 · Sale (S): 3,624 @ $39.58 · Sale (S): 31,392 @ $39.58 · +2 more | EDGAR |
| 2025-09-08 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 1,176,470 @ $25.50 | EDGAR |
| 2025-06-26 | 4 | Artiva Biotherapeutics, Inc. (ARTV) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 13,750 (derivative) @ $0 | EDGAR |
| 2025-06-20 | 4 | Septerna, Inc. (SEPN) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 16,623 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Sionna Therapeutics, Inc. (SION) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 19,959 (derivative) @ $0 | EDGAR |
| 2025-06-10 | 4 | Bicara Therapeutics Inc. (BCAX) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 23,746 (derivative) @ $0 | EDGAR |
| 2025-06-05 | 4 | Climb Bio, Inc. (CLYM) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., RA Capital Nexus Fund II, L.P., Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 40,000 (derivative) @ $0 | EDGAR |
| 2025-03-17 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Purchase (P): 1,296,296 @ $13.50 | EDGAR |
| 2025-02-24 | 4 | Mineralys Therapeutics, Inc. (MLYS) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Grant/award (A): 32,900 (derivative) @ $0 | EDGAR |
| 2025-02-10 | 4 | Sionna Therapeutics, Inc. (SION) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund, L.P., Kolchinsky Peter, Shah Rajeev M. | Conversion (C): 5,021,990 · Conversion (C): 527,444 · Conversion (C): 2,222,084 · Conversion (C): 179,975 · Purchase (P): 1,022,586 @ $18 · Purchase (P): 102,414 @ $18 · +10 more | EDGAR |
| 2024-10-30 | 4 | Septerna, Inc. (SEPN) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Conversion (C): 1,695,515 · Conversion (C): 1,130,343 · Purchase (P): 3,828,400 @ $18 · Purchase (P): 341,600 @ $18 · Conversion (C): 14,598,896 (derivative) · Conversion (C): 9,732,596 (derivative) | EDGAR |
| 2024-09-18 | 4 | Bicara Therapeutics Inc. (BCAX) jointly with RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, Kolchinsky Peter, Shah Rajeev M. | Conversion (C): 2,622,898 · Conversion (C): 2,500,095 · Purchase (P): 1,680,520 @ $18 · Purchase (P): 152,480 @ $18 · Conversion (C): 18,409,755 (derivative) · Conversion (C): 12,273,169 (derivative) · +2 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1883840 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs